Skip to main content

Table 1 Baseline patient characteristics

From: Comparison of vildagliptin twice daily vs. sitagliptin once daily using continuous glucose monitoring (CGM): Crossover pilot study (J-VICTORIA study)

Characteristic Value
Age (years) 55.2 ± 15.5
Gender (M/F) 13/7
Body Mass Index (Kg/m2) 25.1 ± 5.4
Diabetes Duration (years) 4.5 ± 3.7
HbA1c (%) 7.9 ± 0.7
Treatment  
None (diet/exercise) 12
SU 8
  1. HbA1c = glycosylated hemoglobin; SU = sulfonylurea.